Nearly 80 years would pass before the key components of these abnormalities were identified — beginning with the amyloid-β peptide in 1984. In the 1960s, electron microscopy and X-ray ...
Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in ...
The earlier MCI due to AD and mild AD dementia are diagnosed and treated, the greater the opportunity for benefit [1] Last July, the U.S. Food and Drug Administration (FDA) issued a notable ...